High Fatality Rates in Pediatric Multisystem Inflammatory Syndrome: A Multicenter Experience From the Epicenter of

Flávia Jacqueline Almeida1,2,3, Daniel Jarovsky2,3,4, Camila Giuliana Almeida Farias3,5,6

  • 1From the Department of Pediatrics, Santa Casa de São Paulo, São Paulo, Brazil.

Insights

Multisystem inflammatory syndrome in children (MIS-C) in Brazil shows a high case fatality rate, particularly in younger children with Kawasaki disease-like symptoms. Severe cases required intensive care, highlighting the disease

Area of Science:

  • Pediatric Infectious Diseases
  • Critical Care Medicine
  • Epidemiology

Background:

  • Brazil has one of the highest global case fatality rates (CFR) for pediatric multisystem inflammatory syndrome in children and adolescents (MIS-C).
  • Limited comprehensive pediatric data on MIS-C exists for the Brazilian population.

Purpose of the Study:

  • To describe the clinical characteristics, severity, and outcomes of MIS-C in Brazilian children and adolescents.
  • To identify factors associated with severe MIS-C and mortality in this population.

Main Methods:

  • Descriptive analysis of MIS-C cases across 16 hospitals in São Paulo, Brazil.
  • Systematic extraction of clinical and demographic data from electronic medical records.
  • Logistic regression to analyze the effects of MIS-C phenotype, disease severity, and comorbidities.

Main Results:

  • 101 patients met MIS-C criteria; median age was 67 months, with 62.3% admitted to public hospitals.
  • Kawasaki disease-like phenotype (43.5%) was associated with younger age; severe MIS-C cases were older and required intensive care (73.3%), mechanical ventilation (20.8%), and inotropic support (35.6%).
  • A CFR of 3.9% was observed, with three of four deaths occurring in previously healthy children.

Conclusions:

  • MIS-C in Brazilian children presents with a lower median age, especially in Kawasaki disease-like phenotypes.
  • The study confirms increased disease severity and a significant need for intensive care in this population.
  • The high CFR underscores the critical nature of MIS-C in Brazilian pediatric patients.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
243
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.9K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
216
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
287
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
142
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
187